NLRP3 and depressive symptom measurement: Building upon this foundation, further exploration of the upstream molecular mechanisms regulating their release (such as the activation of the NLRP3 inflammasome pathway) may provide crucial insights into the multifaceted molecular processes underlying neuroimmune dysregulation in depression.